Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma

Bone Marrow Transplantation

Volumn 19, Issue 12, 1997, Pages 1247-1250

  Snowden, J A ^a   Patton, W N ^a   O'Donnell, J L ^a   Hannah, E E ^a   Hart, D N J ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Autoimmune disease; Autologous bone marrow transplantation; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; METHOTREXATE; PREDNISONE; STEROID; VINCRISTINE;

ADULT; ARTICLE; AUTOIMMUNITY; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW RESCUE; CASE REPORT; CLINICAL FEATURE; DRUG THERAPY; ETIOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRATHECAL DRUG ADMINISTRATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RELAPSE; REMISSION; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY; THROMBOCYTOPENIA; TREATMENT PLANNING;

EID: 0030749295     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700815     Document Type: Article

References (22)

1. van Bekkum DW, Marmont A, Tyndall A et al. Severe autoimmune diseases: a new target for bone marrow transplantation. Stem Cells 1996; 14: 460-472.
2. Pestronk A, Drachman DB, Teoh R, Adams RN. Combined short term immunotherapy for experimental autoimmune myasthenia gravis. Ann Neurol 1983; 14: 235-241.
3. Knaan-Shanzer S, Houben P, Kinwel-Bohre EPM et al. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1991; 8: 333-338.
4. Slavin S. Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT. Bone Marrow Transplant 1993; 12: 85-88.
5. Roubenoff R, Jones RJ, Karp JE, Stevens MB. Remission of RA with the successful treatment of acute myelogenous leukaemia with cytosine arabinoside, daunorubicin and m-AMSA. Arth Rheum 1987; 30: 1187-1190.
6. Goodwin JS. Remission in systemic lupus erythematosus after combination chemotherapy for Hodgkin's disease. JAMA 1980; 244: 1962.
7. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 1993; 20: 137-140.
8. McKendry RJR, Huebsch L, Le Clair B. Progression of rheumatoid arthritis following bone marrow transplantation: a case report with a 13 year follow up. Arth Rheum 1996; 39: 1246-1253.
9. Euler HH, Marmont AM, Bacigalupo A et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996: 88: 3621-3625.
10. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arth Rheum 1982; 25: 1271-1277.
11. Zander AR, Culbert S, Jagannath S et al. High dose cyclophosphamide, BCNU and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukaemia. Cancer 1987; 59: 1083-1086.
12. Atkinson K, Dodds A, Milliken S et al. Autologous blood stem cell transplantation: treatment related mortality of 2%. ANZ J Med 1995; 25: 483-489.
13. Talmadge JE, Reed EC, Kessinger A el al. Immunologic attributes of cytokine mobilised peripheral blood and recovery following transplantation. Bone Marrow Transplant 1996; 17: 101-109.
14. Mackinnon SE, Barnett L, Heller G, O'Reilly RJ. Minimal residual disease is more common in patients with mixed T-cell chimerism after bone marrow transplantation for chronic myeloid leukaemia. Blood 1994; 83: 3409-3416.
15. Dayal AK, Kammer GM. The T-cell enigma in SLE. Arth Rheum 1995; 39: 23-33.
16. Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilised peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilisation, and composition of the graft. Br J Haematol 1994; 87: 609-613.
17. Cagnoni PJ, Shpall EJ. Mobilisation and selection of CD34-positive haemopoietic progenitors. Blood Rev 1996; 10: 1-7.
18. Kernan N, Collins NH, Juliano L et al. Clonable T-lymphocytes in T-cell depleted bone marrow transplants correlate with development of graft-versus-host disease. Blood 1986; 68: 770-773.
19. Ikehara S, Kawamura M, Takao F et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990; 87: 8341-8344.
20. Lorber M, Gerswin ME, Shonfeld Y. The co-existence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity. Semin Arth Rheum 1994; 24: 105-113.
21. Cahn JY, Chabot J, Esperou H et al. Autoimmune-like thrombocytopenia. Blood 1989; 74: 2771.
22. Snowden JA, Biggs JC, Brooks PM. Autologous blood stem cell transplantation for autoimmune diseases. Lancet 1996; 348: 1112-1113.